| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 05/14/2002 | CA2354832C Chlorella preparations exhibiting immunomodulating properties |
| 05/14/2002 | CA2249180C Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides |
| 05/14/2002 | CA2167090C Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 05/12/2002 | WO2002096204A1 Fungal isolates and biological control compositions for the control of weeds |
| 05/10/2002 | WO2002036811A1 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 05/10/2002 | WO2002036807A2 Compositions and methods relating to breast specific genes and proteins |
| 05/10/2002 | WO2002036806A2 Expression vectors able to elicit improved immune response and methods of using same |
| 05/10/2002 | WO2002036799A2 Extracellular polysaccharide from gluconacetobactor spp |
| 05/10/2002 | WO2002036792A2 Dna expression vectors |
| 05/10/2002 | WO2002036780A2 Stearoyl-coa desaturase gene promoter |
| 05/10/2002 | WO2002036779A1 Novel glucose dehydrogenase and process for producing the dehydrogenase |
| 05/10/2002 | WO2002036773A2 Nod2 nucleic acids and proteins |
| 05/10/2002 | WO2002036771A2 Imaging, diagnosis and treatment of disease |
| 05/10/2002 | WO2002036770A2 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits |
| 05/10/2002 | WO2002036761A2 Compositions and methods for the diagnosis of cancer |
| 05/10/2002 | WO2002036756A2 Lactobacillus strain, and plasmid hosted by same |
| 05/10/2002 | WO2002036746A1 Method for growth of bacteria, minimising the release of endotoxins from the bacteria into the surrounding medium |
| 05/10/2002 | WO2002036745A2 Process for producing freeze dried competent cells and use thereof in cloning |
| 05/10/2002 | WO2002036741A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | WO2002036738A2 Affinity maturation by competitive selection |
| 05/10/2002 | WO2002036735A2 Dry powder cells and cell culture reagents and methods of production thereof |
| 05/10/2002 | WO2002036627A2 Interferons, uses and compositions related thereto |
| 05/10/2002 | WO2002036625A2 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | WO2002036611A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 05/10/2002 | WO2002035934A1 Agents and method of controlling plant foliage diseases |
| 05/10/2002 | WO2002018551A3 Method for producing ligninolytic enzymes using wood-inhabiting fungi from the order agaricales |
| 05/10/2002 | WO2002018342A3 Novel autoinducer molecules and uses therefor |
| 05/10/2002 | WO2002003812A3 Animal feed containing polypeptides |
| 05/10/2002 | WO2002002747A3 Method of improving biomass yield of lactic acid bacterial cultures |
| 05/10/2002 | WO2002000885A9 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 05/10/2002 | WO2001098338A3 Fluorescent proteins |
| 05/10/2002 | WO2001096578A3 Protein production in aureobasidium pullulans |
| 05/10/2002 | WO2001090304A3 Nucleic acids, proteins, and antibodies |
| 05/10/2002 | WO2001087931A3 Bacterial insecticidal proteins |
| 05/10/2002 | WO2001085993A3 Method for detecting growth hormone variations in humans, the variations and their uses |
| 05/10/2002 | WO2001083771A3 Human phospholipase c delta 5 |
| 05/10/2002 | WO2001070808A3 Angiogenesis - associated proteins, and nucleic acids encoding the same |
| 05/10/2002 | WO2001066742A3 G-protein coupled receptors |
| 05/10/2002 | WO2001066594A3 Human protein kinases and protein kinase-like enzymes |
| 05/10/2002 | WO2001066573A3 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 05/10/2002 | WO2001064897A3 Mutant bacterial strains of the genus sphingonomas deficient in production of polyhydroxybutyrate and process of clarification of sphingans |
| 05/10/2002 | WO2001064879A3 G-proteins coupled receptor related polypeptides |
| 05/10/2002 | WO2001062779A3 New transcription factor carp-2 |
| 05/10/2002 | WO2001055323A3 Nucleic acids, proteins, and antibodies |
| 05/10/2002 | WO2001048225A3 Production of heterologous proteins |
| 05/10/2002 | WO2001047963A3 Inhibitors of complement activation, their preparation and use |
| 05/10/2002 | WO2001047962A3 Attenuated microorganisms for the treatment of infection |
| 05/10/2002 | WO2001047955A3 Improvements in or relating to immune responses to hiv |
| 05/10/2002 | WO2001042472A3 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 05/10/2002 | WO2001042451A3 FULL-LENGTH HUMAN cDNAs ENCODING POTENTIALLY SECRETED PROTEINS |
| 05/10/2002 | WO2001042423A3 Compositions and methods for detecting stress-inducible proteins |
| 05/10/2002 | WO2001040478A3 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof |
| 05/10/2002 | WO2001038511A3 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells |
| 05/10/2002 | WO2001036638A3 Polypeptides and nucleic acids encoding same |
| 05/10/2002 | WO2001036487A3 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/10/2002 | WO2001036486A3 Scfv antibodies against disease associated molecules |
| 05/10/2002 | WO2001036467A3 Mammalian receptor proteins; related reagents and methods |
| 05/10/2002 | WO2001036432A3 18 human secreted proteins |
| 05/10/2002 | WO2001034641A8 Antimicrobial activity of the first cationic cluster of human lactoferrin |
| 05/10/2002 | WO2001033199A3 Universal fluorescent sensors |
| 05/10/2002 | WO2001032709A3 Polypeptides with non-natural primary signalling motifs |
| 05/10/2002 | WO2001031007A9 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 05/10/2002 | WO2001030972A3 Regulation of gene expression by neuroleptic agents |
| 05/10/2002 | WO2001027146A9 Chemokine receptor |
| 05/10/2002 | WO2001023533A3 Alzheimer's disease secretase, app substrates therefor, and uses therefor |
| 05/10/2002 | WO2001012827A9 Method for production of transgenic plants with increased tocopherol content |
| 05/10/2002 | WO2001000877A3 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 05/10/2002 | WO2000073349A9 Dr4 antibodies and uses thereof |
| 05/10/2002 | WO2000067761A8 Compositions and methods for identifying antigens which elicit an immune response |
| 05/10/2002 | WO2000058339A3 50 human secreted proteins |
| 05/10/2002 | WO2000046407A3 Methods of utilizing the tt virus |
| 05/10/2002 | CA2427952A1 Dna expression vectors |
| 05/10/2002 | CA2427852A1 Method for growth of bacteria, minimising the release of endotoxins from the bacteria into the surrounding medium |
| 05/10/2002 | CA2427850A1 Interferons, uses and compositions related thereto |
| 05/10/2002 | CA2427802A1 Methods and compositions for the diagnosis of cancer susceptibilites and defective dna repair mechanisms and treatment thereof |
| 05/10/2002 | CA2427800A1 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | CA2427747A1 Affinity maturation by competitive selection |
| 05/10/2002 | CA2427596A1 Dry powder cells and cell culture reagents and methods of production thereof |
| 05/10/2002 | CA2427572A1 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 05/10/2002 | CA2427518A1 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | CA2427436A1 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits |
| 05/10/2002 | CA2427267A1 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 05/10/2002 | CA2427257A1 Expression vectors able to elicit improved immune response and methods of using same |
| 05/10/2002 | CA2427031A1 Novel glucose dehydrogenase and method for producing the dehydrogenase |
| 05/09/2002 | WO2002036803A1 Process for producing d-serine |
| 05/09/2002 | US20020056151 Polypeptide for use as an insecticide; for generation of disease resistant plants |
| 05/09/2002 | US20020055614 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated |
| 05/09/2002 | US20020055476 RAMPs are small proteins that transport calcitonin-receptor-like proteins to the plasma membrane; drug screening |
| 05/09/2002 | US20020055467 Truncated neublastin, of the glial cell-derived nerve growth factor (GDNF) subfamily; when dimerized, binds to a RET (a receptor tyrosine kinase) polypeptide |
| 05/09/2002 | US20020055173 Plasmids for use in expressing heterologous proteins on surface viral particle and for use in gene therapy |
| 05/09/2002 | US20020055169 Method for expression of heterologous proteins in yeast |
| 05/09/2002 | US20020055168 Streptococcus suis vaccines and diagnostic tests |
| 05/09/2002 | US20020055165 Genetically engineered cell; for use a tool in the monitoring of heterologous protein and gene expression in a cell; for use as a tool to generate genome variation in cell |
| 05/09/2002 | US20020055164 Generating preferential particles; obtain cultures, mix with nutrients, recover biopolymer mixture, dry, recover solid particles |
| 05/09/2002 | US20020055163 Amino acid sequences of peptides that are encoded by genes within the human genome, the protease peptides; useful in the development of human therapeutics and diagnostic formulations |
| 05/09/2002 | US20020055160 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/09/2002 | US20020055154 Nucleotide sequences which code for the acp gene |
| 05/09/2002 | US20020055152 Nucleotide sequences which code for the 11dD2 gene |
| 05/09/2002 | US20020055151 Generating preferential amino acid in culture; obtain microorganism which secrete threonine, culture, divide culture, recover preferential amino acid |
| 05/09/2002 | US20020055145 Isolating preferential polypeptide; obtain sample, incubate with ion exchange resin, elute, recover polypeptide |